ANDOVER, Mass., May 02, 2018 -- Omnify Software, a leading provider of web-based Product Lifecycle Management (PLM) software for discrete manufacturers, along with their client, BionX Medical, now Ottobock, the leading global supplier of mechatronic prosthetic and orthotic devices, has been selected as a finalist for the 2018 Medical Design Excellence Awards (MDEA) for the design and development of the Empower prosthetic foot.
Now in its 20th year, the MDEA is the premier awards program for the medtech industry. The awards program celebrates the accomplishments of medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives. They are improving patient healthcare and transforming medtech—one innovation at a time. Omnify was recognized as Ottobock’s PLM supplier helping the company meet time to market, compliance and efficiency goals for a major re-design of the world’s only active prosthetic foot. The Empower is an innovation in the field of prosthetic feet and is equipped with an active ankle joint, making it the only prosthetic foot with powered propulsion.
"We are honored to be recognized for the MDEA alongside our customer," stated Chuck Cimalore, CTO for Omnify Software. "A growing number of medtech companies have adopted our PLM solution to help design safe, innovative, and compliant products and it is great to see our customers recognized for their product achievements."
The 2018 winners will be announced at the MDEA Ceremony on Tuesday, June 12, 2018 in conjunction with the MD&M East event, organized by UBM, taking place at the Jacob K. Javits Convention Center in New York. To learn more about the event please visit: www.MDMeast.com
About Omnify Software
Omnify Software, the leading provider of business-ready Product Lifecycle Management (PLM) solutions for discrete manufacturers, helps OEMs shorten development cycles, accelerate product innovation and improve bottom-line profitability. Omnify's commitment to customer success has resulted in a unique solution that is quick to implement, easy to use, and provides an open integration platform to easily share data with engineering and business systems. Our web-based technology offers flexible deployment options that allow customers to deploy on-premises, in the cloud or via a hybrid approach. Omnify is well-known for superior customer service, delivering outstanding training, development and support with a team of experienced technology professionals. For more information about Omnify Software Product Lifecycle Management, please call 978-988-3800, email [email protected], visit www.omnifysoft.com, or follow us on LinkedIn, Twitter, Facebook or YouTube.
About Ottobock
Ottobock Healthcare develops and pioneers medical technology products and treatment concepts for people with limited mobility in the areas of Prosthetics, Orthotics, Human Mobility (wheelchairs, rehabilitation devices) and MedicalCare. With subsidiaries in more than 50 countries, Ottobock offers “Best in Class” quality worldwide, and employs more than 7,000 team members. A family-managed company since its founding in 1919, Ottobock has also been supporting the Paralympic Games with its technical expertise since 1988.
"Omnify" is a registered trademark of Omnify Software. Any trade, product or service name referenced in this document using the name "Omnify" is a trademark and/or property of Omnify Software. All other trade, product, or service names referenced in this release may be trademarks or registered trademarks of their respective holders.”
Media Contact:
Alaine Portnoy
Omnify Software
[email protected]
978-988-3800
Valerie Harding
Ripple Effect Communications
[email protected]
617-536-8887


Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 



